CHARACTERIZATION OF A TRANSTHYRETIN-RELATED AMYLOID FIBRIL PROTEIN FROM CEREBRAL AMYLOID ANGIOPATHY IN TYPE-I FAMILIAL AMYLOID POLYNEUROPATHY

被引:17
|
作者
KAMETANI, F
IKEDA, S
YANAGISAWA, N
ISHI, T
HANYU, N
机构
[1] SHINSHU UNIV,SCH MED,DEPT MED NEUROL,MATSUMOTO,NAGANO 390,JAPAN
[2] NAGANO RED CROSS HOSP,DEPT NEUROL,NAGANO 380,JAPAN
[3] PSYCHIAT RES INST TOKYO,DEPT MOLEC BIOL,TOKYO 156,JAPAN
[4] PSYCHIAT RES INST TOKYO,DEPT ULTRASTRUCTURE,TOKYO 156,JAPAN
关键词
FAMILIAL AMYLOID POLYNEUROPATHY; CEREBRAL AMYLOID ANGIOPATHY; AMYLOID; TRANSTHYRETIN; AMYLOID FIBRIL PROTEIN; AMINO ACID SEQUENCE;
D O I
10.1016/0022-510X(92)90048-P
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Recently, it has been reported that transthyretin (TTR)-immunoreactive amyloid deposition with cerebral amyloid angiopathy in central nervous system is a common pathological finding in type I familial amyloid polyneuropathy (FAP). In the present study, we performed isolation and sequence analysis of TTR-related amyloid fibril protein from the meninges of a patient with type I FAP. Purified major amyloid fibril protein had a molecular weight of 15 kDa. Complete sequence analysis revealed that this amyloid fibril protein was a variant TTR with a single amino acid substitution of methionine for valine at position 30. This variant TTR is a previously unrecognized as cerebrovascular amyloid fibril protein. Furthermore, the patients with type I FAP are well known to have the variant TTR in the serum. These suggest that cerebrovascular amyloid fibril protein in type I FAP may derive from a serum precursor.
引用
收藏
页码:178 / 183
页数:6
相关论文
共 50 条
  • [1] TRANSTHYRETIN-TYPE CEREBRAL AMYLOID ANGIOPATHY IN TYPE-I FAMILIAL AMYLOID POLYNEUROPATHY
    USHIYAMA, M
    IKEDA, S
    YANAGISAWA, N
    [J]. ACTA NEUROPATHOLOGICA, 1991, 81 (05) : 524 - 528
  • [2] AMYLOID FIBRIL PROTEIN IN TYPE-I FAMILIAL AMYLOIDOTIC POLYNEUROPATHY IN JAPANESE
    TAWARA, S
    ARAKI, S
    TOSHIMORI, K
    NAKAGAWA, H
    OHTAKI, S
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1981, 98 (06): : 811 - 822
  • [3] Liver transplantation in transthyretin-related familial amyloid polyneuropathy
    Stangou, AJ
    Hawkins, PN
    [J]. CURRENT OPINION IN NEUROLOGY, 2004, 17 (05) : 615 - 620
  • [4] Ocular manifestations of transthyretin-related familial amyloid polyneuropathy
    Antoine Rousseau
    Emmanuel Barreau
    Julia Meney
    Zoia Mincheva
    Cécile Cauquil
    Marie Théaudin
    Marc Labetoulle
    David Adams
    [J]. Orphanet Journal of Rare Diseases, 10 (Suppl 1)
  • [5] Cognitive impairment in transthyretin-related familial amyloid polyneuropathy
    Alves, P. N.
    Castro, V.
    Franco, A.
    Martins, I. P.
    Conceicao, I.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 142 - 143
  • [6] AMYLOID FIBRIL PROTEIN IN FAMILIAL AMYLOID POLYNEUROPATHY
    SHOJI, S
    OKANO, A
    [J]. NEUROLOGY, 1981, 31 (02) : 186 - 190
  • [8] Transthyretin-type cerebral amyloid angiopathy: a serious complication in post-transplant patients with familial amyloid polyneuropathy
    Sekijima, Yoshiki
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015, 86 (02): : 124 - 124
  • [9] A prospective study of ocular manifestations in transthyretin-related familial amyloid polyneuropathy
    Meney, Julia
    Barreau, Emmanuel
    Mincheva, Zoia
    Theaudin, Marie
    Cauquil, Cecile
    Labeyrie, Celine
    Kaswin, Godefroy
    Adams, David
    Labetoulle, Marc
    Rousseau, Antoine
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [10] Transthyretin related familial amyloid polyneuropathy
    Planté-Bordeneuve, V
    Said, G
    [J]. CURRENT OPINION IN NEUROLOGY, 2000, 13 (05) : 569 - 573